- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Integral Diagnostics Ltd (IDX)
The Integral Diagnostics Ltd share price today is 2.28, view ASX IDX stock exchange data. Track the latest Integral Diagnostics Ltd share price with real-time updates on IDX stock performance including market cap, day range, 52-week range and dividend yield. Access IDX charts, earnings dates and analyst estimates to support your investment decisions.
Sydney
Currency in AUD
2.28
-0.01(-0.44%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.27
2.31
52 wk Range
1.91
2.97
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.272.31
52 wk Range
1.912.97
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.06%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.06%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IDX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
3.01
Upside
+32.08%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
12 Buy
2 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.01
(+32.08% Upside)
Integral Diagnostics Ltd Earnings Call Summary for H2/2026
- Integral Diagnostics reported FY2026 revenue up 25.6% to AUD 788.7M; operating NPAT rose 50.1% to AUD 47.4M; shares climbed 6.58% to $2.43.
- Capitol Health integration delivered AUD 14M in synergies, exceeding targets; operating EBITDA margin improved to 20.9% from 20.1% prior year.
- Operating free cash flow increased 30.7% to AUD 106.4M with 82% conversion; leverage declined to 2.3x EBITDA from 2.6x at June 2025.
- Management guided FY2027 operating EBITDA margin above 21.0%; final dividend raised 50% to AUD 0.06 per share, fully franked.
- New CEO Jason Martinez emphasized execution over reinvention; strategic review of New Zealand operations underway, including potential divestment.
Last Updated: 25-08-2026, 08:10 am
Read Full TranscriptEarnings
Latest Release
24-08-2026
EPS / Forecast
0.03 / 8.00
Revenue / Forecast
395.14M / 285M
Compare IDX to Peers and Sector
Metrics to compare | IDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 38.7x | 18.4x | −0.4x | |
PEG Ratio | 0.07 | 0.04 | 0.00 | |
Price/Book | 1.3x | 1.3x | 2.6x | |
Price / LTM Sales | 1.1x | 0.8x | 3.0x | |
Upside (Analyst Target) | 39.3% | 19.9% | 55.1% | |
Fair Value Upside | Unlock | 16.6% | 8.2% | Unlock |
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquartered in East Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Integral Diagnostics Ltd (IDX) Share Price Today?
The Integral Diagnostics Ltd share price today is 2.28.
What is the current Integral Diagnostics Ltd (IDX) share price and day range?
As of 13-09-2026, the Integral Diagnostics Ltd share price is 2.28, with a previous close of 2.28. The share price has ranged from 2.27 to 2.31 today, while the 52-week range spans from 1.91 to 2.97.
What Is the Integral Diagnostics Ltd Market Cap?
As of today, Integral Diagnostics Ltd market cap is 849.27M.
Does Integral Diagnostics Ltd Pay Dividends? What's The Current Dividend Yield?
The Integral Diagnostics Ltd dividend yield is 4.06%.
What Is the Integral Diagnostics Ltd (IDX) Share Price Target?
The average 12-month share price target for Integral Diagnostics Ltd is 3.01, with a high estimate of 3.7 and a low estimate of 2.24. 12 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +32.08% Upside potential.
What Is Integral Diagnostics Ltd's Earnings Per Share (TTM)?
The Integral Diagnostics Ltd EPS (TTM) is 0.06.
From a Technical Analysis Perspective, Is IDX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does Integral Diagnostics Ltd Trade On?
Integral Diagnostics Ltd is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Integral Diagnostics Ltd?
The stock symbol for Integral Diagnostics Ltd is "IDX."
How Many Times Has Integral Diagnostics Ltd Stock Split?
Integral Diagnostics Ltd has split 1 times.
How Many Employees Does Integral Diagnostics Ltd Have?
Integral Diagnostics Ltd has 3049 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.